EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieMultizentrische StudieOpen Access · CC BY-NC 4.0

Efficacy and safety of community‐based moxibustion for primary hypertension: A randomized controlled trial with patient preference arms

Xu Zhou, Qiuyun Xue, Jianyu You, Shuqing Li, Ling Li, Weifeng Zhu, Yong Fu iD, Xin Sun

The Journal of Clinical Hypertension · 2023

DOI: 10.1111/jch.14738 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift The Journal of Clinical Hypertension, 2023. Verfasst von Xu Zhou und 7 weiteren Autor:innen. Beteiligte Einrichtung: Evidence-Based Medicine Research Center, Jiangxi University of Chinese Medicine, Nanchang, China. Hauptthemen laut MEDLINE: Hypertension, Moxibustion. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Natural Science Foundation of China, National Science Fund for Distinguished Young Scholars, Young Qihuang Scholar Project of National Administration of Traditional Chinese Medicine.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Moxibustion has been shown to have a potential antihypertensive effect, but its applicability for the primary care of hypertension is unclear. The authors conducted a multicenter randomized controlled trial (RCT) with patient preference arms to investigate the effect, safety, cost‐effectiveness, and compliance of moxibustion in community patients with hypertension. Patients with primary hypertension were enrolled from seven communities randomly or nonrandomly assigned to receive self‐administered moxibustion + the original hypertensive regimen or the original hypertensive regimen alone for 6 months. The authors mainly evaluated the effects of moxibustion on hypertensive outcomes and adverse events. As a result, a total of 160 and 240 patients were recruited into the randomized and nonrandomized arms, respectively, with 87.5% completing the follow‐up. At month 6, there was a significantly greater reduction in systolic blood pressure (SBP) (difference: −10.57 mmHg), a higher proportion of responders (82.2% vs. 53.7%; odds ratio 4.00), and better improvements in hypertensive symptoms and quality of life (QoL) in the moxibustion group than in the control group in the randomized population, but there was no significant between‐group difference in diastolic blood pressure (DBP). The nonrandomized findings showed the same effect direction for all outcomes, except for DBP. All moxibustion‐related adverse events were mild. In conclusion, moxibustion can reduce SBP and improve hypertensive symptoms and QoL in community patients with hypertension, with good safety and low cost, although its effect on DBP remains uncertain. The findings suggest that moxibustion may be an appropriate technique for community primary care of hypertension.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HypertensionMoxibustionHumansAntihypertensive AgentsBlood PressureEssential HypertensionPatient Preference

Stichwörter der Autor:innen

communitymoxibustionpatient preference trialprimary hypertensionrandomized controlled trial

Substanzen

Antihypertensive Agents

Autor:innen und Institutionen

  • Evidence-Based Medicine Research Center, Jiangxi University of Chinese Medicine, Nanchang, China.
  • Graduate School, Jiangxi University of Chinese Medicine, Nanchang, China.
  • Chinese Evidence-Based Medicine Centre, West China Hospital, Sichuan University, Chengdu, China.
  • First Department of Acupuncture and Moxibustion, The Affiliated Hospital of Jiangxi University of Chinese Medicine, Nanchang, China.

ORCID-Profile: Yong Fu

Förderung

  • National Natural Science Foundation of China
  • National Science Fund for Distinguished Young Scholars
  • Young Qihuang Scholar Project of National Administration of Traditional Chinese Medicine
  • China Medical Board
  • Jiangxi University of Chinese Medicine Science and Technology Innovation Team Development Program
  • Top Discipline of Jiangxi Province, Discipline of Chinese and Western Integrative Medicine, Jiangxi University of Chinese Medicine

Zitieren

APA

Zhou, X., Xue, Q., You, J., Li, S., Li, L., Zhu, W., Fu, Y., & Sun, X. (2023). Efficacy and safety of community‐based moxibustion for primary hypertension: A randomized controlled trial with patient preference arms. The Journal of Clinical Hypertension. https://doi.org/10.1111/jch.14738

Vancouver

Zhou X, Xue Q, You J, Li S, Li L, Zhu W, et al. Efficacy and safety of community‐based moxibustion for primary hypertension: A randomized controlled trial with patient preference arms. The Journal of Clinical Hypertension. 2023. doi:10.1111/jch.14738

BibTeX
@article{Zhou2023,
  author = {Zhou, Xu and Xue, Qiuyun and You, Jianyu and Li, Shuqing and Li, Ling and Zhu, Weifeng and Fu, Yong and Sun, Xin},
  title = {Efficacy and safety of community‐based moxibustion for primary hypertension: A randomized controlled trial with patient preference arms},
  journal = {The Journal of Clinical Hypertension},
  year = {2023},
  doi = {10.1111/jch.14738}
}
Kostenlos starten →